Desperate patients get early access to experimental cachexia drug
Symptom relief
NO_LONGER_AVAILABLE
This program gives seriously ill adults with advanced pancreatic cancer and severe weight loss (cachexia) access to an experimental drug called mifomelatide before it is officially approved. It is for patients who have no other good treatment options for their weight loss and can…
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC